Asia Pacific Antibody Production Market Report

Asia Pacific Antibody Production Market by Process, by End User, Region, Trends, Competitive Analysis, and Growth Opportunities, Key Insights.
Published On—
Speak To Analyst

Executive Summary

Asia-Pacific Antibody Production Market from Consainsights analyses the Asia-Pacific Antibody Production Market in the Life Sciences industry over the forecast period to 2026.

Asia-Pacific Antibody Production research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Asia-Pacific Antibody Production segmentation includes Process, End User and Geography.

Market analysis on the basis of Process include Upstream Processing, Downstream Processing, Ion Exchange (IEX) Chromatography Resins, Hydrophobic Interaction Chromatography (HIC) Resins, Multimodal Chromatography Resins, Filtration. This segmentation encompasses the key innovations and micro & macro trends, companies/manufacturers operating in this space along with their usage and penetration with respect to the wide range of End Users. Additionally, market sizing information along with the key factors such as market drivers, restraints, opportunities and challenges which are likely to be influencing the market growth are outlined in this report.

Based on the End User, the Asia-Pacific Antibody Production Market analysis covers Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories, Research Institutes.

Key companies operating in the market include GE Healthcare (A SUBSidiary of General Electric Company), Merck KGAA, Thermo Fisher Scientific, Inc., Sartorius AG, Pall Corporation (Acquired By Danaher Corporation), Sigma-Aldrich Corporation (Acquired By Merck KGAA), Eppendorf AG and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions, Partnerships and so on along with the expansion areas focusing on the additional geographies, future insights for success and market share analysis. Major players strategies include the launch of the innovative product lines along with the emphasis on the partnerships and acquisitions to standardize their market share in the market space.

Market Research methodology includes the triangulation of the data from the data sources such as Primary Market Research approach and Secondary Market Research Approach along with the data from the trade bodies and industry standard publications and data sources. Primary inputs from the industry experts and the market respondents from the respective industries to obtain very critical information to assess the future growth prospects of the market. The final data is triangulated and thoroughly validated considering all the data sources using the bottom-up and the top-down approaches to estimate the market sizing of the individual segments.

Report Metric

Details

Market size available for years

2017-2026

Base year considered

2020

Forecast period

2021-2026

Forecast units

Value (USD Billion)

Segments covered

Process, End User

Countries covered

China, Japan, India, Southeast Asia, Australia & New Zealand, Rest of Asia-Pacific

Companies Covered

GE Healthcare (A SUBSidiary of General Electric Company), Merck KGAA, Thermo Fisher Scientific, Inc., Sartorius AG, Pall Corporation (Acquired By Danaher Corporation), Sigma-Aldrich Corporation (Acquired By Merck KGAA), Eppendorf AG, Cellab GmbH, Integra Biosciences AG, Fibercell Systems Inc.

The Asia-Pacific Antibody Production Market is segmented into the following categories:

Asia-Pacific Antibody Production Market by Process:

  • Ion Exchange (IEX) Chromatography Resins

  • Hydrophobic Interaction Chromatography (HIC) Resins

  • Multimodal Chromatography Resins

Asia-Pacific Antibody Production Market by End User:

  • Pharmaceutical and Biotechnology Companies

  • Diagnostic Laboratories

  • Research Institutes

Table of Contents

  1. Executive Summary

  2. Asia-Pacific Antibody Production Market Overview

    1. Asia-Pacific Antibody Production Market Definition & Scope
    2. Currency, Year and Forecasts Overview
    3. Asia-Pacific Antibody Production Market 360° Synopsis: Overview
  3. Asia-Pacific Antibody Production Industry Analysis

    1. Industry Value Chain Analysis
    2. Key Companies at each phase of Value Chain
    3. Industry Trend Analysis
  4. Asia-Pacific Antibody Production Market Analysis

    1. Drives, Restraints, Opportunities and Challenges Impact Analysis
    2. Porter’s Five Force Model Analysis
    3. PESTLE Analysis
    4. BPS Analysis
    5. Asia-Pacific Antibody Production Market Key Innovation & Trends
    6. Pricing Patterns (Company & Product Type)
  5. Asia-Pacific Antibody Production Market: Process

    1. Introduction
    2. Upstream Processing: Market Trends, Size, and Forecast (2017-2026)

      1. Bioreactors
      2. Consumables
    3. Downstream Processing: Market Trends, Size, and Forecast (2017-2026)

      1. Chromatography Instruments
      2. Chromatography Resins
    4. Ion Exchange (IEX) Chromatography Resins: Market Trends, Size, and Forecast (2017-2026)
    5. Hydrophobic Interaction Chromatography (HIC) Resins: Market Trends, Size, and Forecast (2017-2026)
    6. Multimodal Chromatography Resins: Market Trends, Size, and Forecast (2017-2026)
    7. Filtration: Market Trends, Size, and Forecast (2017-2026)

      1. Filtration Systems
      2. Filtration Consumables and Accessories
  6. Asia-Pacific Antibody Production Market: End User

    1. Introduction
    2. Pharmaceutical and Biotechnology Companies: Market Trends, Size, and Forecast (2017-2026)
    3. Diagnostic Laboratories: Market Trends, Size, and Forecast (2017-2026)
    4. Research Institutes: Market Trends, Size, and Forecast (2017-2026)
  7. Asia-Pacific Antibody Production Market: Country

    1. Introduction
    2. China: Market Trends, Size, and Forecast (2017-2026)
    3. Japan: Market Trends, Size, and Forecast (2017-2026)
    4. India: Market Trends, Size, and Forecast (2017-2026)
    5. Southeast Asia: Market Trends, Size, and Forecast (2017-2026)
    6. Australia & New Zealand: Market Trends, Size, and Forecast (2017-2026)
    7. Rest of Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)
  8. Asia-Pacific Antibody Production Market: Company Analysis

    1. Introduction
    2. GE Healthcare (A SUBSidiary of General Electric Company)

      1. Overview
      2. Business Portfolio
      3. Product Portfolio
      4. Key Brands Insights
      5. Company SWOT & Strategic Analysis
      6. Company Financials
      7. Analyst Insights
    3. Merck KGAA

    4. Thermo Fisher Scientific, Inc.

    5. Sartorius AG

    6. Pall Corporation (Acquired By Danaher Corporation)

    7. Sigma-Aldrich Corporation (Acquired By Merck KGAA)

    8. Eppendorf AG

    9. Cellab GmbH

    10. Integra Biosciences AG

    11. Fibercell Systems Inc.

  9. Asia-Pacific Antibody Production Market: Competitive Analysis

    1. Strategic Dashboard of Top Market Players
    2. Companies Deals (Mergers, Partnerships, Acquisitions, JVs)
    3. Expansion Areas (Based on Company Analysis)
    4. Market Share Analysis
  10. Asia-Pacific Antibody Production Market: Distribution Channel Analysis

    1. Distributor Type Analysis
    2. Major Distributors (Key Countries)
    3. Future Growth Prospects
  11. Industry & Analysts Insights for Success

  12. Research Methodology

  13. Appendix

    1. List of Tables
    2. List of Figures
    3. Available Customizations
    4. Related Reports

List of Figures

Figure 1: Asia-Pacific Antibody Production Market: Structure

Figure 2: Asia-Pacific Antibody Production Market: Value Chain Analysis

Figure 3: Asia-Pacific Antibody Production Market: Porter's Five Forces Model

Figure 4: Asia-Pacific Antibody Production Market: Market Dynamics

Figure 5: Asia-Pacific Antibody Production Market, By Process, 2017-2026 (USD Million)

Figure 6: Asia-Pacific Antibody Production Market, By End User, 2017-2026 (USD Million)

Figure 7: China Antibody Production Market, By Process, 2017-2026 (USD Million)

Figure 8: China Antibody Production Market, By End User, 2017-2026 (USD Million)

Figure 9: Japan Antibody Production Market, By Process, 2017-2026 (USD Million)

Figure 10: Japan Antibody Production Market, By End User, 2017-2026 (USD Million)

Figure 11: India Antibody Production Market, By Process, 2017-2026 (USD Million)

Figure 12: India Antibody Production Market, By End User, 2017-2026 (USD Million)

Figure 13: Southeast Asia Antibody Production Market, By Process, 2017-2026 (USD Million)

Figure 14: Southeast Asia Antibody Production Market, By End User, 2017-2026 (USD Million)

Figure 15: Australia & New Zealand Antibody Production Market, By Process, 2017-2026 (USD Million)

Figure 16: Australia & New Zealand Antibody Production Market, By End User, 2017-2026 (USD Million)

Figure 17: Rest of Asia-Pacific Antibody Production Market, By Process, 2017-2026 (USD Million)

Figure 18: Rest of Asia-Pacific Antibody Production Market, By End User, 2017-2026 (USD Million)

List of Tables

Table 1: Asia-Pacific Antibody Production Market, By Process, 2017-2026 (USD Million)

Table 2: Asia-Pacific Antibody Production Market, By End User, 2017-2026 (USD Million)

Table 3: China Antibody Production Market, By Process, 2017-2026 (USD Million)

Table 4: China Antibody Production Market, By End User, 2017-2026 (USD Million)

Table 5: Japan Antibody Production Market, By Process, 2017-2026 (USD Million)

Table 6: Japan Antibody Production Market, By End User, 2017-2026 (USD Million)

Table 7: India Antibody Production Market, By Process, 2017-2026 (USD Million)

Table 8: India Antibody Production Market, By End User, 2017-2026 (USD Million)

Table 9: Southeast Asia Antibody Production Market, By Process, 2017-2026 (USD Million)

Table 10: Southeast Asia Antibody Production Market, By End User, 2017-2026 (USD Million)

Table 11: Australia & New Zealand Antibody Production Market, By Process, 2017-2026 (USD Million)

Table 12: Australia & New Zealand Antibody Production Market, By End User, 2017-2026 (USD Million)

Table 13: Rest of Asia-Pacific Antibody Production Market, By Process, 2017-2026 (USD Million)

Table 14: Rest of Asia-Pacific Antibody Production Market, By End User, 2017-2026 (USD Million)

Research Methodology

Introduction

This research study extensively involved secondary and primary data sources. Initially, all the important terms and processes related to the Asia Pacific Antibody Production market were identified. Then, each of these terms was clearly defined and relationships were established among them in the form of parent market, peer markets, and child markets. The entire value-chain was also studied to distinguish various solution and service providers that are operating in the global Asia Pacific Antibody Production market and how the services are being delivered or consumed in every phase of the value chain. The overall objective of this process was to identify the important segments of the Asia Pacific Antibody Production market that meet two important criteria– 1) their revenue is derivable using assumptions and expert opinions 2) their definitions are unique and non-overlapping.

After defining the market segments, the supply side analysis was carried out where the individual players operating in various segments of the Asia Pacific Antibody Production market were identified and their revenues were analyzed to derive the segmental shares. The derived shares were also validated through an extensive demand side analysis. The below figure depicts different phases of the report production process.

Phases of the report production process

Secondary Research

This research study was initiated with detailed study of information available in the public domain and paid databases. Various secondary sources that were referred during this study include company websites, product descriptions, whitepapers, survey papers, annual reports, investor presentations, press releases, blogs, news, journals, magazines; audit reports, articles published by associations, and paid databases, such as Factiva, D&B Hoovers, and Bloomberg BusinessWeek. The key objective behind secondary research was to obtain information regarding the market evolution, ecosystem, value-chain, total pool of solution and service providers, market segmentation, recent developments, upcoming opportunities and challenges, and various factors that are impacting the market. These data were further validated through primary research.

Primary Research

In primary research, various industry experts from both supply and demand side were interviewed to obtain critical information on competitive landscape, vendor shares, value-chain, pricing strategy, and adoption trends. The primary sources include industry experts, such as CXOs, Vice Presidents, Marketing Directors, Technology Directors, and Business Development Managers of companies that are operating in the global Asia Pacific Antibody Production market. Primary research was also conducted to validate the market segmentations, industry trends, market size, future prospects for market growth, and key strategies adopted by the major players to gain leading position in the market.

Market Size Estimation And Forecasting

This research study followed two approaches to estimate and forecast the size of global Asia Pacific Antibody Production market and its sub-segments– top-down and bottom-up approach. Important data those were used during this process include list of top players operating in the market, their share in the market, and total pool of solution and service providers. This entire process includes the study of annual and financial reports and extensive interview with industry experts across the value-chain. All important factors that are impacting the market were analyzed and verified through primary research. These data were consolidated and processed through an in-house developed market intelligence engine to derive the final quantitative data.

Top-Down Approach

The top-down approach was employed to derive the global Asia Pacific Antibody Production market size through vendor share analysis. More than 40 key players were analyzed and their total contribution in the global market size was found to be around 70%. Thus, remaining 30% was extrapolated to arrive at the global Asia Pacific Antibody Production market size. The regional and country level performance of these top players was also studied to derive the market share for different regions and countries.

Phases of the report production process

Bottom-Up Approach

After the top-down approach, bottom-up approach was employed to derive the share and size for other market segments. Initially, the segmental shares were estimated at the country level. Then, the country- level market numbers were added to derive the regional sizes and finally, by adding the regional sizes, global sizes of all the market segments were calculated.

Phases of the report production process

List of Assumptions

  • Market Estimates and Forecasting: The market is estimated and forecasted in the realistic manner, instead of optimistic/aggressive way.
  • Currency: All the revenue-related market numbers are shown in globally accepted currency, USD.
  • Exchange Rates and Currency Conversion: For conversion of other currencies to USD, the average exchange rate for that particular year was used. OANDA website was used for all currency conversions in this market study.
  • Dollar Fluctuation: Dollar fluctuations are assumed to be moderate and will not affect the market forecasts during the forecast period.
  • Global Economic Conditions: The global economic conditions are assumed to be stable enabling the market to grow with similar rate as it’s been growing from last four years.
  • Qualitative to Quantitative Data Conversion: This market study extensively covers numerous factors that are impacting the global Asia Pacific Antibody Production market. In certain cases, direct quantitative data were not available to clearly indicate their influencing power on the market. To handle such cases, a rating mechanism was applied that was purely based on the understanding of the experts involved in the study.